Clinical trial Recruiting at 5 sites Observational Ages 18 to 110

Improving quality of life after heart valve replacement

Official title: Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation

Run by Sheba Medical Center · NCT02023060 · Data updated 2026-11-12

This study looks at how people feel and do after getting a heart valve replacement to see if there are patterns that could help improve future treatments.

Quick facts

Study typeObservational
Ages18 Years to 110 Years
SexAll
Enrollment100 (estimated)
SponsorSheba Medical Center
Government
Locations5 sites (Jerusalem and 4 other locations)
StatusRecruiting
StartedNovember 2013
Main results expectedNovember 2030
Study endsNovember 2030
Registry record updatedNovember 29, 2023
Trial IDNCT02023060 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients selected for transcatheter heart valve replacement who can provide informed consent.

Probably not a fit

Patients who are unable to provide informed consent or are pregnant may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to track patient characteristics and outcomes following transcatheter heart valve replacement for aortic or mitral valve conditions. By collecting data over time, the study seeks to identify trends that may inform future treatment approaches. Participants will be those selected for the procedure and who provide informed consent. The study does not involve any specific interventions beyond observation.

Why it matters

Potential benefit: If successful, this study could enhance understanding of patient outcomes and improve quality of life for individuals undergoing heart valve replacement.

How similar studies have gone: Other observational studies have shown success in tracking patient outcomes in similar heart valve replacement procedures, suggesting that this approach is validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Subject selected for transcatheter heart valve replacement
2. Signed informed consent to participate in the study

Exclusion Criteria:

1. Inability to sign written informed consent.
2. Pregnancy or breast feeding (women of childbearing potential will have a serum or urine pregnancy test).

Where it's running

  • Hadassah Medical Center
    Jerusalem, Israel
    Recruiting
  • Shaarei Zedek amedical Center
    Jerusalem, Israel
    Recruiting
  • Rabin Medical Center
    Petah Tikva, Israel
    Recruiting
  • Sheba Medical Center
    Ramat Gan, Israel
    Recruiting
  • Tel Aviv Medical Center
    Tel Aviv, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.